Quest Diagnostics Income After Taxes 2010-2024 | DGX

Quest Diagnostics annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Quest Diagnostics income after taxes for the quarter ending September 30, 2024 was $0.231B, a 0% increase year-over-year.
  • Quest Diagnostics income after taxes for the twelve months ending September 30, 2024 was $868M, a 8.77% increase year-over-year.
  • Quest Diagnostics annual income after taxes for 2023 was $0.882B, a 9.17% decline from 2022.
  • Quest Diagnostics annual income after taxes for 2022 was $0.971B, a 51.5% decline from 2021.
  • Quest Diagnostics annual income after taxes for 2021 was $2.002B, a 40.59% increase from 2020.
Quest Diagnostics Annual Income After Taxes
(Millions of US $)
2023 $882
2022 $971
2021 $2,002
2020 $1,424
2019 $829
2018 $744
2017 $789
2016 $657
2015 $730
2014 $561
2013 $824
2012 $666
2011 $494
2010 $745
2009 $767
Quest Diagnostics Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $231
2024-06-30 $240
2024-03-31 $200
2023-12-31 $197
2023-09-30 $231
2023-06-30 $242
2023-03-31 $212
2022-12-31 $113
2022-09-30 $270
2022-06-30 $246
2022-03-31 $342
2021-12-31 $388
2021-09-30 $501
2021-06-30 $640
2021-03-31 $473
2020-12-31 $567
2020-09-30 $576
2020-06-30 $189
2020-03-31 $92
2019-12-31 $256
2019-09-30 $208
2019-06-30 $202
2019-03-31 $163
2018-12-31 $127
2018-09-30 $218
2018-06-30 $222
2018-03-31 $177
2017-12-31 $257
2017-09-30 $166
2017-06-30 $198
2017-03-31 $168
2016-12-31 $158
2016-09-30 $194
2016-06-30 $200
2016-03-31 $105
2015-12-31 $192
2015-09-30 $353
2015-06-30 $122
2015-03-31 $63
2014-12-31 $176
2014-09-30 $132
2014-06-30 $142
2014-03-31 $111
2013-12-31 $127
2013-09-30 $412
2013-06-30 $161
2013-03-31 $124
2012-12-31 $149
2012-09-30 $167
2012-06-30 $184
2012-03-31 $166
2011-12-31 $186
2011-09-30 $182
2011-06-30 $172
2011-03-31 $-46
2010-12-31 $161
2010-09-30 $208
2010-06-30 $204
2010-03-31 $171
2009-12-31 $191
2009-09-30 $201
2009-06-30 $198
2009-03-31 $177
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.877B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00